story of the week
A CTC-Derived RNA Signature Predicts Early Therapeutic Response in Localized and Metastatic Breast Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Cancer Discovery
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
A Digital RNA Signature of Circulating Tumor Cells Predicting Early Therapeutic Response in Localized and Metastatic Breast Cancer
Cancer Discov 2018 Aug 13;[EPub Ahead of Print], TT Kwan, A Bardia, LM Spring, A Giobbie-Hurder, M Kalinich, T Dubash, T Sundaresan, X Hong, JA LiCausi, U Ho, EJ Silva, BS Wittner, LV Sequist, R Kapur, DT Miyamoto, M Toner, DA Haber, S MaheswaranFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.